Anti-NRP1 peptide-engineered ROS/pH dual-responsive nanoparticles for Alpelisib delivery regulate Sema3A-NRP1/PI3K-AKT signaling to balance oxidative stress and inhibit angiogenesis in endometriosis.
Authors: Zhang J, Zhang H, Liu W, Zhang Y, Hou W, Chi C
Journal: Journal of nanobiotechnology
group therapy
mental health
open access